Lista de obras - Nikoloz Chkhartishvili - Dominio Público Uruguay

Assessment of quality of life in people living with HIV in Georgia.

artículo científico publicado en 2016

Cascade of care among HIV patients diagnosed in 2013 in Georgia: Risk factors for late diagnosis and attrition from HIV care

artículo científico publicado en 2017

Characteristics of HIV-infected women and factors associated with HCV seropositivity in the Republic of Georgia

artículo científico publicado en 2011

Characterization of HIV-1 subtypes and drug resistance mutations among individuals infected with HIV in Georgia

artículo científico publicado en 2012

Clinical outcomes of two-drug regimens vs. three-drug regimens in antiretroviral treatment-experienced people living with HIV

artículo científico publicado en 2020

Distinct drug resistance profile of HIV-1 subtype A strain circulating in Georgia

artículo científico publicado en 2015

Epidemiology of human immunodeficiency virus (HIV) drug resistance in HIV patients with virologic failure of first-line therapy in the country of Georgia

artículo científico publicado en 2018

Estimating HIV incidence in eastern European country of Georgia: 2010-2012.

artículo científico publicado en 2014

Evaluation of multiple measures of antiretroviral adherence in the Eastern European country of Georgia

artículo científico publicado en 2014

Expansion of CD3/CD16/CD56 positive NKT cells in HIV/AIDS: the pilot study.

artículo científico publicado en 2008

HIV care in Central and Eastern Europe: How close are we to the target?

artículo científico publicado en 2018

HLA-B*5701 genetic screening prior to abacavir prescription in Georgia.

artículo científico publicado en 2010

High incidence of the hepatitis C virus recombinant 2k/1b in Georgia: Recommendations for testing and treatment

artículo científico publicado en 2015

IL28B favorable genotype and ultrarapid viral response as the earliest treatment predictors of a sustained viral response in a Georgian cohort infected with the hepatitis C genotype 1.

artículo científico publicado en 2012

INCIDENCE OF TUBERCULOSIS AMONG HIV/HCV CO-INFECTED PATIENTS RECEIVING HEPATITIS C TREATMENT WITH PEGYLATED INTERFERON AND RIBAVIRIN IN GEORGIA.

artículo científico publicado en 2016

Impact of hepatitis C virus antibody positivity on mortality and causes of death in people living with HIV in Georgia

artículo científico publicado en 2019

Impact of hepatitis C virus recombinant form RF1_2k/1b on treatment outcomes within the Georgian national hepatitis C elimination program

artículo científico publicado en 2017

Late presentation of HIV infection in the country of Georgia: 2012-2015.

artículo científico publicado en 2017

Linkage and retention in HCV care for HIV-infected populations: early data from the DAA era.

artículo científico publicado en 2018

Mismatch between physicians and family members views on communications about patients with chronic incurable diseases receiving care in critical and intensive care settings in Georgia: a quantitative observational survey

artículo científico publicado en 2016

Mortality and causes of death among HIV-infected individuals in the country of Georgia: 1989-2012.

artículo científico publicado en 2014

National Progress Toward Hepatitis C Elimination - Georgia, 2015-2016.

artículo científico publicado en 2016

Outcomes of Universal Access to Antiretroviral Therapy (ART) in Georgia

artículo científico publicado en 2011

Persistent disparities in antiretroviral treatment (ART) coverage and virological suppression across Europe, 2004 to 2015

Poor agreement between interferon-gamma release assays and the tuberculin skin test among HIV-infected individuals in the country of Georgia

artículo científico publicado en 2013

Prevalence of hepatitis B and C among HIV positive patients in Georgia and its associated risk factors.

artículo científico publicado en 2008

Progress Toward Achieving the UNAIDS 90-90-90 Goals in HIV Care From Diagnosis to Durable Viral Suppression in the Country of Georgia

artículo científico publicado en 2017

Re-treatment of patients with hepatitis C who failed to respond (nonresponders) to previous treatment.

artículo científico publicado en 2009

Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia: results of hepatology clinic HEPA

artículo científico publicado en 2017

Significant Improvements Are Needed in HIV Care Continuum to Meet 90-90-90 Targets in Georgia

artículo científico publicado en 2016

Successful application of laboratory tools for the detection of HIV drug resistance in routine clinical care in Georgia

article

The Attitudes, Needs, and Requirements at End of Life in the Republic of Georgia (Comparative Analysis of Groups of Patients With Cancer and Elders)

artículo científico publicado en 2018

The cascade of care in the Eastern European country of Georgia

artículo científico publicado en 2014

The natural history of recent hepatitis C virus infection among blood donors and injection drug users in the country of Georgia

artículo científico publicado en 2016

Uptake of HCV treatment in HIV/HCV coinfected patients across europe in the era of direct-acting antivirals

article

Uptake of hepatitis C virus treatment in HIV/hepatitis C virus-coinfected patients across Europe in the era of direct-acting antivirals

article

Variation in antiretroviral treatment (ART) coverage and virological suppression among three HIV key populations

article

Virologic outcomes of second-line antiretroviral therapy in Eastern European country of Georgia

artículo científico publicado en 2014

Lista de obras de Nikoloz Chkhartishvili

Assessment of quality of life in people living with HIV in Georgia.

Cascade of care among HIV patients diagnosed in 2013 in Georgia: Risk factors for late diagnosis and attrition from HIV care

Characteristics of HIV-infected women and factors associated with HCV seropositivity in the Republic of Georgia

Characterization of HIV-1 subtypes and drug resistance mutations among individuals infected with HIV in Georgia

Clinical outcomes of two-drug regimens vs. three-drug regimens in antiretroviral treatment-experienced people living with HIV

Distinct drug resistance profile of HIV-1 subtype A strain circulating in Georgia

Epidemiology of human immunodeficiency virus (HIV) drug resistance in HIV patients with virologic failure of first-line therapy in the country of Georgia

Estimating HIV incidence in eastern European country of Georgia: 2010-2012.

Evaluation of multiple measures of antiretroviral adherence in the Eastern European country of Georgia

Expansion of CD3/CD16/CD56 positive NKT cells in HIV/AIDS: the pilot study.

HIV care in Central and Eastern Europe: How close are we to the target?

HLA-B*5701 genetic screening prior to abacavir prescription in Georgia.

High incidence of the hepatitis C virus recombinant 2k/1b in Georgia: Recommendations for testing and treatment

IL28B favorable genotype and ultrarapid viral response as the earliest treatment predictors of a sustained viral response in a Georgian cohort infected with the hepatitis C genotype 1.

INCIDENCE OF TUBERCULOSIS AMONG HIV/HCV CO-INFECTED PATIENTS RECEIVING HEPATITIS C TREATMENT WITH PEGYLATED INTERFERON AND RIBAVIRIN IN GEORGIA.

Impact of hepatitis C virus antibody positivity on mortality and causes of death in people living with HIV in Georgia

Impact of hepatitis C virus recombinant form RF1_2k/1b on treatment outcomes within the Georgian national hepatitis C elimination program

Late presentation of HIV infection in the country of Georgia: 2012-2015.

Linkage and retention in HCV care for HIV-infected populations: early data from the DAA era.

Mismatch between physicians and family members views on communications about patients with chronic incurable diseases receiving care in critical and intensive care settings in Georgia: a quantitative observational survey

Mortality and causes of death among HIV-infected individuals in the country of Georgia: 1989-2012.

National Progress Toward Hepatitis C Elimination - Georgia, 2015-2016.

Outcomes of Universal Access to Antiretroviral Therapy (ART) in Georgia

Persistent disparities in antiretroviral treatment (ART) coverage and virological suppression across Europe, 2004 to 2015

Poor agreement between interferon-gamma release assays and the tuberculin skin test among HIV-infected individuals in the country of Georgia

Prevalence of hepatitis B and C among HIV positive patients in Georgia and its associated risk factors.

Progress Toward Achieving the UNAIDS 90-90-90 Goals in HIV Care From Diagnosis to Durable Viral Suppression in the Country of Georgia

Re-treatment of patients with hepatitis C who failed to respond (nonresponders) to previous treatment.

Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia: results of hepatology clinic HEPA

Significant Improvements Are Needed in HIV Care Continuum to Meet 90-90-90 Targets in Georgia

Successful application of laboratory tools for the detection of HIV drug resistance in routine clinical care in Georgia

The Attitudes, Needs, and Requirements at End of Life in the Republic of Georgia (Comparative Analysis of Groups of Patients With Cancer and Elders)

The cascade of care in the Eastern European country of Georgia

The natural history of recent hepatitis C virus infection among blood donors and injection drug users in the country of Georgia

Uptake of HCV treatment in HIV/HCV coinfected patients across europe in the era of direct-acting antivirals

Uptake of hepatitis C virus treatment in HIV/hepatitis C virus-coinfected patients across Europe in the era of direct-acting antivirals

Variation in antiretroviral treatment (ART) coverage and virological suppression among three HIV key populations

Virologic outcomes of second-line antiretroviral therapy in Eastern European country of Georgia